Company Ceapro Inc. Other OTC
Equities
CRPOF
CA1499071076
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 06-12-31 |
Director of Finance/CFO | - | 15-05-04 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Chief Tech/Sci/R&D Officer | - | 09-12-31 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 19-01-06 |
52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 06-12-31 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 15-04-26 |
William Li
BRD | Director/Board Member | 61 | 14-11-19 |
Ronald Miller
CHM | Chairman | - | 22-03-01 |
Geneviève Foster
BRD | Director/Board Member | - | 22-04-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,293,177 | 76,755,900 ( 98.04 %) | 0 | 98.04 % |
Company contact information
![address Ceapro Inc.(CRPOF)](https://cdn.zonebourse.com/static/address/72988.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+31.04% | 52.73B | |
+37.49% | 39B | |
-9.23% | 38.52B | |
+27.94% | 30.38B | |
-12.26% | 26.39B | |
+11.29% | 26.08B | |
+44.68% | 14.15B | |
+32.67% | 12.6B | |
-5.40% | 11.51B |